Advanced search×

PharmGKB summary: methotrexate pathway.

Torben S TS Mikkelsen, Caroline F CF Thorn, Jun J JJ Yang, Cornelia M CM Ulrich, Deborah D French, Gianluigi G Zaza, Henry M HM Dunnenberger, Sharon S Marsh, Howard L HL McLeod, Kathy K Giacomini, Mara L ML Becker, Roger R Gaedigk, James Steven JS Leeder, Leo L Kager, Mary V MV Relling, William W Evans, Teri E TE Klein, and Russ B RB Altman

Pharmacogenet Genomics 21(10):679-86 (2011) PMID 21317831

DOI: 10.1097/FPC.0b013e328343dd93
Version: za2963e q8za6 q8zb2 q8zc8 q8zd7 q8ze0 q8zf0 q8zg1
View PDF

Similar articles you may find interesting…

  1. Thiopurine pathway.
    Gianluigi G Zaza, Meyling M Cheok, ... Russ B RB Altman

    Pharmacogenet Genomics 20(9):573-4 (2010) PMID 19952870

    View PDF
  2. Iloperidone: A new drug for the treatment of schizophrenia.
    Sally A SA Arif and Melissa M MM Mitchell

    Am J Health Syst Pharm 68(4):301-8 (2011) PMID 21289324

    Purpose The pharmacology, pharmacokinetics, pharmacogenomics, clinical efficacy, and safety and tolerability profile of iloperidone for the treatment of schizophrenia are reviewed. Summary Iloperidone is an atypical antipsychotic that recently received marketing approval from the Food and Drug Admin...
    Buy PDF
  3. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.
    M V Relling, E E Gardner, ... T E Klein

    Clin Pharmacol Ther 89(3):387-91 (2011) PMID 21270794

    We provide dosing recommendations (updates at http://www.pharmgkb.org) for azathioprine, mercaptopurine (MP), and thioguanine based on TPMT genotype....
    View PDF